{
  "ticker": "LLY",
  "target_date": "2025-11-25",
  "actual_date": "2025-11-25",
  "collected_at": "2025-12-08T12:34:42.796754",
  "price": {
    "open": 1075.83,
    "high": 1111.11,
    "low": 1073.25,
    "close": 1109.93994140625,
    "volume": 4181500,
    "change_1d_pct": 3.72,
    "change_7d_pct": 8.26,
    "change_30d_pct": 36.83
  },
  "technicals": {
    "rsi_14": 90.08,
    "sma_20": 975.06,
    "sma_50": 868.33,
    "macd": 64.742,
    "macd_signal": 57.065,
    "macd_histogram": 7.677,
    "bb_upper": 1141.22,
    "bb_lower": 808.9,
    "price_vs_sma20_pct": 13.83,
    "price_vs_sma50_pct": 27.82,
    "volume_ratio": 0.87
  },
  "fundamentals": {
    "market_cap": 891759362048,
    "pe_ratio": 48.738853,
    "forward_pe": 43.899384,
    "price_to_book": 37.453316,
    "price_to_sales": 15.007781,
    "profit_margin": 30.99,
    "operating_margin": 48.29,
    "roe": 96.47,
    "roa": 17.6,
    "revenue_growth": 53.9,
    "earnings_growth": 480.4,
    "debt_to_equity": 178.516,
    "current_ratio": 1.546,
    "quick_ratio": 0.724,
    "dividend_yield": 59.0,
    "fifty_two_week_high": 1111.99,
    "fifty_two_week_low": 623.78,
    "fifty_day_avg": 911.5326,
    "two_hundred_day_avg": 811.9354,
    "analyst_target": 1056.7045,
    "analyst_recommendation": "buy",
    "num_analysts": 27,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - General",
    "pct_from_52w_high": -10.54,
    "pct_from_52w_low": 59.47
  },
  "macro": {
    "spy": {
      "price": 675.02,
      "change_1d_pct": 0.94,
      "change_7d_pct": 1.4
    },
    "vix": {
      "level": 18.56,
      "signal": "NORMAL"
    },
    "treasury_10y": {
      "yield_pct": 4.0
    },
    "dollar_index": {
      "level": 99.66
    },
    "gold": {
      "price": 4139.2
    },
    "regime": "BULL_NORMAL"
  },
  "news": [
    {
      "headline": "Here's Why Novo Nordisk Stock Popped Today",
      "source": "Yahoo",
      "datetime": 1764095861,
      "summary": "Good news from a GLP-1 receptor agonist clinical trial hit the market today.",
      "url": "https://finnhub.io/api/news?id=0e2b12bd139d542c75dee527f96dfd8a0d14d173a42ede7ecb98aaaa2ae4f596"
    },
    {
      "headline": "Rigel Pharmaceuticals: Behind The Huge Rally",
      "source": "SeekingAlpha",
      "datetime": 1764093660,
      "summary": "Rigel Pharmaceuticals, Inc. posted a solid Q3 with robust sales growth. Discover insights on future profitability and market outlook. Click for this RIGL update.",
      "url": "https://finnhub.io/api/news?id=10fbd8308888c851886c7082538a7288263114dce4c7cb41a05476e07a17c038"
    },
    {
      "headline": "Novo's Comeback Shot? Weight-Loss Drug Triggers Surprise Rally After Brutal Stock Crash",
      "source": "Yahoo",
      "datetime": 1764093487,
      "summary": "A promising next-gen diabetes treatment just gave Novo Nordisk its first real jolt of hope in months.",
      "url": "https://finnhub.io/api/news?id=1ec5cab16dd847471c0de510fd905da76bdc43e7c06b216c974d7118b57ccaef"
    },
    {
      "headline": "Top analyst drops jaw-dropping price target on Eli Lilly stock",
      "source": "Yahoo",
      "datetime": 1764091980,
      "summary": "Bernstein just threw fresh fuel on Eli Lilly's (LLY) never-ending rally, as the firm lifted its price target on the stock to $1,300 from $1,100. For perspective, that\u2019s an 18% bump compared to the old target, while representing a 21% to 22% upside compared to Lilly\u2019s current stock price. ...",
      "url": "https://finnhub.io/api/news?id=da8967cdebc44d4eba388b37def20950b2eee8f03f4f1fd2e1b4dd234f4193c4"
    },
    {
      "headline": "Novo Nordisk Stock Jumps on Positive Weight-Loss Drug Data. Why It Deserves Better.",
      "source": "Yahoo",
      "datetime": 1764082260,
      "summary": "Shares, though, were punished Monday after the drug maker said its blockbuster obesity treatment Wegovy failed to slow Alzheimer\u2019s.",
      "url": "https://finnhub.io/api/news?id=b0283a3dc8885651cfbff03768f4cf3481f167d55b85a0fa96030016cb3178f1"
    }
  ],
  "news_count": 5,
  "sec_filings": [
    {
      "form": "4",
      "date": "2025-11-25",
      "description": "xslF345X05/form4-11252025_041101.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000031601125000089/xslF345X05/form4-11252025_041101.xml"
    },
    {
      "form": "4",
      "date": "2025-11-24",
      "description": "xslF345X05/form4-11242025_041101.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000031601125000087/xslF345X05/form4-11242025_041101.xml"
    },
    {
      "form": "8-K",
      "date": "2025-11-21",
      "description": "lly-20251118.htm",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000271/lly-20251118.htm"
    },
    {
      "form": "4",
      "date": "2025-11-21",
      "description": "xslF345X05/form4-11212025_041101.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000031601125000083/xslF345X05/form4-11212025_041101.xml"
    },
    {
      "form": "4",
      "date": "2025-11-20",
      "description": "xslF345X05/form4-11202025_041101.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000031601125000081/xslF345X05/form4-11202025_041101.xml"
    }
  ],
  "sec_filings_count": 5,
  "data_quality": {
    "has_price": true,
    "has_technicals": true,
    "has_fundamentals": true,
    "has_macro": true,
    "has_news": true,
    "has_sec_filings": true
  }
}